Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Leukemia"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&filter%5B%5D=topic_facet%3A%22Leukemia%22
/vufind/Search/Results?lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&filter%5B%5D=topic_facet%3A%22Leukemia%22
Search /vufind/Search2/Results?lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&filter%5B%5D=topic_facet%3A%22Leukemia%22
PubPharm (5.672)
1
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia : Phase II Study of Treatment of Acute Promyelocytic Leukemia (APL) With ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin (GO)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders : Myeloablative Allogeneic Hematopoietic Cell Transplantation Using a Related or Unrelated Donor for the Treatment of Hematological Diseases
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL : A Randomized, Multicenter, Open-Label, Phase 3 Study to Compare the Efficacy and Safety of Acalabrutinib (ACP-196) in Combination With Venetoclax With and Without Obinutuzumab Compared to Investigator's Choice of Chemoimmunotherapy in Subjects With Previously Untreated Chronic Lymphocytic Leukemia Without Del(17p) or TP53 Mutation (AMPLIFY)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CML : CD34 Selected Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning and CD8+ Memory T Cell Infusion For Patients With Myelodysplastic Syndrome, Acute Leukemia, and Chronic Myelogenous Leukemia
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study : Randomized, Phase III Study of Early Intervention With Venetoclax and Obinutuzumab Versus Delayed Therapy With Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): EVOLVE CLL/SLL Study
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants With Relapsed, Refractory, or Newly Diagnosed Cancers : An Open-label, Multicenter, Phase 1a/1b Study of Aplitibart (IGM-8444) as a Single Agent and in Combination in Participants With Relapsed, Refractory, or Newly Diagnosed Cancers
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Flotetuzumab for Relapsed Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Following Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) : A Phase 2 Trial Evaluating the Efficacy of Flotetuzumab (MGD006) for Relapsed Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Following Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
VOB560-MIK665 Combination First in Human Trial in Patients With Hematological Malignancies (Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory Multiple Myeloma) : A Phase Ib, Multicenter Study of VOB560 in Combination With MIK665 in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory Multiple Myeloma.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Palbociclib in Combination With Chemotherapy in Pediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (RELPALL2) : A Phase1 Study at Stanford of Palbociclib in Combination With Chemotherapy in Pediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (RELPALL2)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma : A Phase III Prospective, Multicenter, Randomized, Open-Label Trial of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[568]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Leukemia
Medienart
5.672
Aufsätze
5.672
E-Artikel
5.672
E-Ressourcen
Zeitschriftentitel
5.672
ClinicalTrials.gov
Thema
5.672
610
Leukemia
4.823
Study Type: Interventional
2.578
Leukemia, Myeloid
2.204
Recruitment Status: Completed
2.166
Leukemia, Myeloid, Acute
2.062
Leukemia, Lymphoid
1.622
Phase: Phase 2
1.592
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1.329
Phase: Phase 1
1.317
Recruitment Status: Recruiting
1.162
Leukemia, Lymphocytic, Chronic, B-Cell
1.115
Myelodysplastic Syndromes
1.005
Lymphoma
806
Preleukemia
788
Study Type: Observational
765
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
682
Recruitment Status: Terminated
628
Syndrome
601
Recruitment Status: Active, not recruiting
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3.450
2020-
2.124
2010-2019
98
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
5.672
Englisch
Haven't found what you're looking for?
Wird geladen...